Is serum pepsinogen testing necessary in populationbased screening for gastric cancer?
Yeon-Ji Kim, Woo Chul Chung
Korean J Intern Med. 2020;35(3):544-546. Published online 2020 Apr 29 DOI: https://doi.org/10.3904/kjim.2020.139
Citations to this article as recorded by 
Enhancing gastric cancer early detection: A multi-verse optimized feature selection model with crossover-information feedback
Jiejun Lin, Fangchao Zhu, Xiaoyu Dong, Rizeng Li, Jisheng Liu, Jianfu Xia
Computers in Biology and Medicine.2024; 175: 108535. CrossRef
PG I and PG II show unique value in diagnosing postoperative biochemical recurrence in patients with gastric cancer after total gastrectomy
Jiuru Zhang, Jiameng Liu, Liyang Dong, Xi Wang, Xueqian Mao, Yufei Mao, Chaoming Mao
Discover Oncology.2024;[Epub] CrossRef
Value of serum G-17, PGI, PGII, Hp-IgG in the screening of gastric cancer and precancerous lesions and its relationship with the depth of tumor invasion
Qian Sheng, Guo-Dong Zhang, Min-Ya Wen
World Chinese Journal of Digestology.2022; 30(5): 235. CrossRef
Clinical Study of Serological Detection in Patients with Gastric Cancer
沛 郭
Medical Diagnosis.2022; 12(02): 201. CrossRef
Current Evidence for a Paradigm Shift in Gastric Cancer Prevention From Endoscopic Screening toHelicobacter pyloriEradication in Korea
Young-Il Kim, Il Ju Choi
Journal of Gastric Cancer.2022; 22(3): 169. CrossRef
Diagnostic performances of pepsinogens and gastrin-17 for atrophic gastritis and gastric cancer in Mongolian subjects
Ganchimeg Dondov, Dashmaa Amarbayasgalan, Batbold Batsaikhan, Tegshjargal Badamjav, Batchimeg Batbaatar, Baljinnyam Tuvdenjamts, Nasanjargal Tumurbat, Bayar Davaa, Erkhembulgan Purevdorj, Bayarmaa Nyamaa, Tulgaa Lonjid, Muhammad Tarek Abdel Ghafar
PLOS ONE.2022; 17(10): e0274938. CrossRef